FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Amy Schumer promises 'disappointing lap dance' for winner of TrainWreck Premiere contest to support MS research




















Image source: REALLIFESTL

Amy Schumer, writer and star of the upcoming comedy, TrainWreck, has promised a 'disappointing lap dance' for the winner of Universal's TrainWreck Premiere Experience hosted on CrowdRise to benefit the National Multiple Sclerosis (MS) Society, an organization that is very dear to her heart.
Read more »

Labels:


 

Researchers Offer New Insights into the Link Between Multiple Sclerosis and Specific Autoantibodies


































Researchers at Immco Diagnostics and the State University of New York in Buffalo recently reported in the journal PLoS One that the frequency of specific auto reactive antibodies does not differ between patients with multiple sclerosis (MS) and people without the disease — a finding that could lead to improvements in diagnosis. The study is entitled “Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.”
Read more »

 

Nursing service problems remain
























Clare Curran
Image source: OTAGODAILYTIMES

A Dunedin MP and a multiple sclerosis sufferer say problems in the Royal District Nursing Service have still not been fixed. They spoke to health reporter Eileen Goodwin.
Read more »

 

Girl, 7, swims to raise funds for MS

























Olivia Moore, a 7-year-old swimmer from Aurora, will swim a mile Saturday to raise money for multiple sclerosis research. Her mother, Leanne, recently was diagnosed with the disease.
Photo by Daily Herald Staff Photographer Christie Willhite

Seven-year-old Olivia Moore of Aurora is using her love of swimming to help raise money to improve the lives of those living with multiple sclerosis.
Read more »

 

Long-term (up to 4.5 years) treatment with Gilenya (fingolimod) in multiple sclerosis: results from the extension of the randomised TRANSFORMS study: STUDY

Monday

 

How Multiple Sclerosis did not deter this woman from fulfilling her passions and dreams




















Swarnalatha

Five years ago Swarnalatha was diagnosed with Primary Progressive Multiple Sclerosis, a condition that gradually worsens. She was completely shattered. “I couldn’t’t imagine the embarrassment my family had to bear. The second option was to crib, complain, and grieve about my condition. I enjoyed being sympathized with. Eventually, I got sick of this phase; since it didn’t’t help me in any way. Then I tried the last option – of being proactive,” says Swarnalatha.
Read more »

Labels: ,


 

Medical Marijuana: Not Your Dad's Weed: AUDIO



























It took Connecticut nearly two years to start dispensing the medical marijuana the legislature approved for conditions like Multiple Sclerosis, epilepsy and cancer.
Read more »

Labels: ,


 

First generic multiple sclerosis drug, made in Cambridge, launches




















Image source: DRUGDISCOVERY

Cambridge-based Momenta Pharmaceuticals and partner Sandoz announced plans late yesterday to launch the first generic drug in the U.S. to treat multiple sclerosis, priced 15 percent less than the branded version of the drug.
Read more »

Labels:


 

MedDay Reports Additional Positive Data of its Pivotal Phase III Study With MD1003 in Patients with Progressive Multiple Sclerosis

























Image source: DDDMAG
  • Improvement of Clinical Global Impression of change evaluated by the physician (CGI) and by the patient (SGI) at 12 months (p<0.0001 and p=0.0094 respectively) 
  • Data to be presented at The 1stCongress of the European Academy of Neurology on Saturday 20th June at 17:30 noon CET 
Read more »

Labels: , ,


 

Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis: STUDY





















Image source: DIZZINESS-AND-BALANCE
Read more »

Labels: ,


Sunday

 

Understanding Tremors in Multiple Sclerosis




























Image source: DRUGLINE

Tremors are one of the more common symptoms of multiple sclerosis. This uncontrollable shaking can be especially bothersome, embarrassing, and debilitating at times, but there are ways to help manage it.
Read more »

 

Canadians with Multiple Sclerosis One Step Closer to Accessing LEMTRADA®

























Image source: FOURSEASONCANUCK

Genzyme Canada announced today that the Canadian Drug Expert Committee (CDEC), through the Common Drug Review (CDR), recommended to all participating provincial and other public drug plans that LEMTRADA® (alemtuzumab) be listed for the management of adult patients with relapsing-remitting multiple sclerosis (RRMS). Eligible patients with active disease defined by clinical and imaging features, and who have had an inadequate response to interferon beta or other disease-modifying therapies.
Read more »

Labels:


 

Ontario invests $25 million in stem cell research over five years


































Ontario is investing $25 million over five years in stem cell research that will help support treatments for chronic diseases like cancer, multiple sclerosis and diabetes.
Read more »

Labels:


 

Animal Models Offer New Insights Into Energy Metabolism in Multiple Sclerosis





























Researchers at United Arab Emirates University in Abu Dhabi have recently published in the journal BMC Neuroscience new insights into the involvement of mitochondria and energy metabolism in the pathology of multiple sclerosis (MS) in rats. The study is entitled “Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.”
Read more »

 

Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis: STUDY



























Image source: 3DMD

Read more »

Labels:


Saturday

 

Anxiety, Pain Share a Strong Bond in Multiple Sclerosis





































Image source: NYMAG

Pain, which is prevalent in more than 50% of multiple sclerosis (MS) patients, is independently predicted by anxiety, according to a study published in Pain Medicine.
Read more »

Labels: ,


 

Alcoholism and Multiple Sclerosis
























Image source: ALCOHOLIC

Learn about your risk for alcoholism and what to do if you may have a problem.
Read more »

 

Innovative “Nanoprobe” Used to Diagnose Multiple Sclerosis




























A nanometric sensor — an extremely small probe originally designed to test samples for the presence of herbicides, heavy metals, and pollutants — was experimentally shown to also detect molecules commonly associated with multiple sclerosis. Physicist Fábio de Lima Leite, a professor at the Federal University of São Carlos (UFSCar), Sorocaba, has been studying how this device may help diagnose diseases of the nervous system.
Read more »

 

Trends in MS research: New antigen-specific treatment approaches – individualised therapy remains key goal












































Image source: HEALTHTAP

More than 500,000 people in Europe suffer from multiple sclerosis. New treatment approaches such as antigen-specific immunisation strategies are among the topical MS research areas discussed at the Congress of the European Academy of Neurology in Berlin. Experts urged for the development of truly individualised therapy approaches in order to use available drugs in a more targeted way.
Read more »

 

Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials: STUDY



























"Generations"
Image source: BBCNEWS
Read more »

Labels:


Friday

 

MedDay Reveals Promising Data on Progressive Multiple Sclerosis Therapy

























MedDay, a biotechnology company dedicated to developing therapies for nervous system disorders, recently announced encouraging data on its pivotal Phase III clinical trial (MS-SPI) assessing the safety and efficacy of the company’s investigational therapy MD1003 for the treatment of progressive multiple sclerosis (MS). The data was presented at The 1st Congress of the European Academy of Neurology (EAN), held June 20 to 23, 2015 in Berlin, Germany.
Read more »

Labels: ,


 

HIV and MS: Could a Link Lead to New MS Treatment: VIDEO

























Two clinical trials are now underway that offer the first tests of an intriguing but still not widely accepted theory of multiple sclerosis -- that its trigger lies within a part of the human genome that medical research has largely ignored.
Read more »

Labels:


 

Brevard ophthalmologist: Multiple sclerosis affects vision





























Patients with MS frequently have visual symptoms. The ophthalmologist is often the first physician consulted

When optic nerves become inflamed with demyelination, pain frequently follows as well as vision abnormalities including blurry images, flashings, loss of color vision, depth perception problems and dark spots centered in visual fields. Vision loss may occur, though usually in only one eye at a time. Fortunately, except in rare cases, normal vision returns when the inflammation subsides. The exceptions usually involve color and diminished depth perception.
Read more »

 

Two Reviews Find Substantial Evidence That Marijuana Relieves Pain, Nausea, and Spasticity





















The current issue of The Journal of the American Medical Association includes two articles that review studies of marijuana's medical utility and come to similar conclusions about the applications that are best supported by the existing evidence: treatment of chronic pain, neuropathic pain, and spasticity. There is also substantial evidence that THC, marijuana's main active ingredient, is effective at relieving nausea and restoring appetite.
Read more »

Labels:


 

7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis: STUDY


































































Image source: JAMANETWORK
Read more »

Thursday

 

The Osmonds and MS: Like Father, Like Son






















Alan Osmond and his son David have both been honored with the National Multiple Sclerosis Society Spirit of Life Award.

Charisma and musicality aren’t the only things David Osmond has in common with his father, Alan Osmond, a founding member of the iconic 1970s musical group The Osmonds. Both men live with forms of multiple sclerosis (MS).
Read more »

 

Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis





















Representation of an enzyme (upper part of image) fixed to the tip of an atomic force microscope capturing herbicide molecules on a surface (lower part of image). Credit: GNN/UFSCar

The nanobiosensor was developed at the Federal University of São Carlos (UFSCar), Sorocaba, in partnership with the São Paulo Federal Institute of Education, Science & Technology (IFSP), Itapetininga, São Paulo State, Brazil. It was originally designed to detect herbicides, heavy metals and other pollutants. An article about the nanobiosensor has just been published as a cover feature by IEEE Sensors Journal.
Read more »

 

Reversing Multiple Sclerosis Damage with Topical Medications
































The damage caused by multiple sclerosis (MS) may be able to be reduced using 2 topical medicines typically used for skin conditions, according to findings published in the journal Nature.
Read more »

 

In middle of MS battle, pioneering foundation closing its doors

















































Multiple sclerosis patient Scott Johnson started the Myelin Repair Foundation in 2003

The Myelin Repair Foundation, founded by a multiple sclerosis patient to speed new approaches for battling the debilitating disease, will close Aug. 31 due to financial problems, the nonprofit said in a message on its website Monday.
Read more »

 

Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil: STUDY
























Image source: MUNDIBLOG
Read more »

Labels:


Wednesday

 

Disgusted wife blasts Jobcentre officials who ordered her husband to attend interview despite the fact that he cannot walk, talk or feed himself


































Nick Gaskin, 46, was ordered to attend a 'work-focused interview' at his local job centre despite only being able to communicate by blinking because he suffers from primary progressive multiple sclerosis
  • Nick Gaskin, 46, suffers from primary progressive multiple sclerosis
  • From Quorn, Leicestershire, he was diagnosed in 1999 and has 24/7 care
  • He communicates by blinking with his wife Tracy, 41, his full time carer
  • Department of Work and Pensions 'sorry' for interview request letter
Read more »

 

Q&A With Anne Cross from Washington University School of Medicine: Additional Treatments Could Provide Benefit to Patients With Multiple Sclerosis: VIDEO




























The development of new monoclonal antibodies could provide benefit for patients with multiple sclerosis in the future. Exactly how they will be used and what their usage could mean for treatment remains to be determined.
Read more »

Labels:


 

Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis





















Image source: SKINSENSE101

Patients with progressive multiple sclerosis (MS) and their clinicians see clear improvements during treatment with a high dose of biotin, show further results from the phase III trial of the therapy.
Read more »

 

New Survey Finds Nearly 1 in 6 MS Patients Use Medical Pot
























One-quarter of patients with multiple sclerosis report having used cannabis therapeutically and nearly one out of six (16 percent) currently use it to treat symptoms of the disease, according to survey data commissioned by the North American Research Committee on MS.
Read more »

Labels:


 

Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia: STUDY






















British Columbia Flag
Image source: WIKIMEDIACOMMONS
Read more »

Labels:


Tuesday

 

Study Shows Vitamin D Supplementation in Pregnant Women With MS Positively Impacts Disease Severity
























In women of childbearing age, low vitamin D levels are a common issue often resulting from low intake of vitamin D (in food) and/or inadequate sunlight exposure, although other less frequent causes exist, including genetic disorders and pregnancy. The most identified consequence of vitamin D deficiency in women is sub-optimal bone mineralization, leading to osteomalacia and osteoporosis. Vitamin D deficiency is a health issue for many women, however, low levels of active vitamin D are particularly associated with multiple sclerosis (MS) development and progression as well.
Read more »

Labels: ,


 

Dad with MS raising funds for stem cell transplant in Mexico: VIDEO



















A Burlington dad with multiple sclerosis is hoping a controversial and costly stem cell transplant in Mexico will do for him what a similar treatment appears to have done for hockey legend Gordie Howe.
Read more »

Labels: ,


 

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS














Image source:MULTIPLESCLEROSISNEWSTODAY

MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis. The data, to be announced on Saturday 20th June at The 1st Congress of the European Academy of Neurology (EAN), shows an improvement of the Clinical Global Impression of change observed after 12 months of treatment with MD1003 and confirms the positive results presented at the American Academy of Neurology in April 2015.
Read more »

Labels: ,


 

A mother with MS is fighting to clear her sons name




























Team Toney, which is what one mother has started to help clear her son’s name; a team fighting because a mother’s love is unconditional. After O'Shay Toney was recently charged in a serious crime, his mother stepped up on his behalf to do everything in her power to protect her son and attempts to help clear his name.
Read more »

 

Cognitive evolution in Tysabri treated Multiple Sclerosis patients: STUDY

Monday

 

With spa's founder fighting MS, husband steps in









































Christina Rossetti Thompson and her husband, Victor Thompson, operate Greentoes, an ecofriendly manicure and pedicure studio and day spa at 529 N. Sixth Ave. Not long after she got her new business going, Christina began dealing with the effects of multiple sclerosis.
Image source: TUCSON.COM

Christina Rossetti Thompson had been living with multiple sclerosis almost as long as she had been a school teacher when she had the dream that would change both her and her husband’s lives.
Read more »

Labels:


 

Abingtons woman encourages fellow multiple sclerosis patients
































Peggy Carrick

When the symptoms of multiple sclerosis attempt to weigh down Peggy Carrick, her faith and spirit keep her afloat.
Read more »

Labels:


 

Gov. Baker OKs waiver for Massachusetts’ 1st pot dispensary
























Gov. Charlie Baker on Friday issued a one-time, temporary waiver aimed at helping the state’s first marijuana dispensary begin selling pot for medicinal purposes.
Read more »

Labels:


 

Researchers Suggest Short Transition Period Between Tysabri (Natalizumab) and Gilenya (Fingolimod) Therapies to Control RRMS Disease Activity




























An international team led by researchers at the University Hospital Basel in Switzerland revealed that a short period of 8 to 12 weeks is the optimal timing to be considered when patients with relapsing-remitting multiple sclerosis (RRMS) are switched from natalizumab to fingolimod therapy. The study was recently published in the journal Neurology and is entitled “Switching from natalizumab to fingolimod, A randomized, placebo-controlled study in RRMS.”
Read more »

Labels: , , ,


 

GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of Copaxone (glatiramer acetate) 40 mg/ml three-times weekly versus 20 mg/ml daily in patients with relapsing-remitting multiple sclerosis: STUDY





Image source: PHARMAFILE
Read more »

Labels: ,


Sunday

 

Discovering New Biomarkers and Immune Regulation























Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
Read more »

 

Getting creative for fundraiser

























In a fundraising environment where thousands of worthy charities are clamoring for the attention and donations of relatively few people willing to give, it takes something big and unusual to get noticed.
Read more »

 

Fairfield student gets National MS Society scholarship























































Image source: FAIRFIELDCITIZENONLINE

Volunteer, captain and coach are the usual titles associated with Fairfield’s Caroline Pangallo. But this month, she earned a new one: recipient of the National MS Society, Connecticut Chapter, 2015 Hayley’s Hope and Michaela’s Miracle MS Memorial Fund Scholarship.
Read more »

 

Relief for Natco: US court junks Teva’s patent on Copaxone






















In a relief to Natco Pharma, the US court of appeals has invalidated Teva’s Copaxone patent. This may help generic pharma companies to launch one of the top-selling multiple sclerosis drugs, Copaxone.
Read more »

Labels:


 

Complement C1q-C3–associated synaptic changes in multiple sclerosis hippocampus: STUDY


Go to Newer News Go to Older News